Khavinson BioregulatorTarget: LungsRespiratory

Chonluten

Glu-Asp-Gly · EDG · Lung Bioregulator Tripeptide · Хонлутен

Chonluten is synthetic Glu-Asp-Gly (EDG), an airway cytogen. It is not Honluten (a lung-extract catalog SKU). The one-letter name collision is how people buy the wrong bottle.

Not FDA-approved - research chemical

Quick answer

What it is: Chonluten is synthetic Glu-Asp-Gly (EDG), an airway cytogen.

Class and target: Cytogen (synthetic short peptide) · Lungs and bronchi · sequence EDG

Typical research dose: 1–2 capsules/day (Cytomed) or 1–2 mg SC (research vial)

Reconstitution calculator ↓What it is & the evidence on The Bioregulator Atlas →

Research summary, not medical advice.

Reviewed by Kymata Health Editorial Team
Last updated: August 2026Evidence: Low3 peer-reviewed citations
Typical research dose
1–2 capsules/day (Cytomed) or 1–2 mg SC (research vial)
Frequency
1× daily for 10-30 day cycles
Half-life
Short (tripeptide)
Common vials
5 mg / 10 mg
CAS
N/A
Molecular weight
319.27 g/mol

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

  • Longevity / aging3.5/10

    Khavinson-school tissue peptide. Single-lab concentration after haircut. Not a Western Phase 3 geroprotector.

  • Immune3/10

    Respiratory aisle in the school. Not an asthma drug.

Compound card

Sequence
EDG
Class
Khavinson cytogen (EDG)
Formula
C11H17N3O8
Status
Not FDA-approved · research use
Dose it
5 mg + 2.5 mL BAC water → 2 mg/mL · 1000 mcg ≈ 50 units (U-100)
Open in calculator

How it works

Chonluten (Glu-Asp-Gly) is a tripeptide bioregulator targeting the lungs and gastric mucosa. It primarily acts on the respiratory epithelial cells to reduce inflammation, improve oxygen transfer capacity, and support lung tissue regeneration. It is frequently utilized in protocols for respiratory aging, post-infection recovery, and environmental toxin (e.g., smoking) damage.

Source: PMID: 11713572

Khavinson map

Canonical 41
Class
Cytogen (synthetic short peptide)
Organ
Lungs and bronchi
Target
Lungs
System
Respiratory
Sequence
EDG · Glu-Asp-Gly
Pair
Taxorest (bronchial Cytomax); Bronchogen is the other airway cytogen
Хонлутен

Used in bioregulator stacks

Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.

The Khavinson school

Chonluten is filed here as cytogen (synthetic short peptide), targeting the lungs and bronchi. Khavinson's St. Petersburg group moved from organ extracts (Cytamins) to capsule complexes (Cytomaxes) to synthetic short peptides (Cytogens); most of the evidence comes from that one group, with little independent Western replication.

Read the full background, the proposed epigenetic mechanism, the literature limits, and how we count the canonical 41 on the Khavinson bioregulators index.

History of this molecule

NPCRIZ lists both Chonluten and Bronchogen on the cytogen poster - lungs/bronchi versus a more bronchial-specific tetrapeptide (AEDL). Taxorest is the official Cytomax for bronchial mucosa. Honluten is a separate extract SKU in Western menus and is not on the e-peptide 21.

EDG is mucosa/surfactant-adjacent in the school’s telling. It is not a LABA. It is not nintedanib. Post-viral fibrosis YouTube protocols are not a substitute for pulmonary rehab and actual imaging.

Caveats

A defined sequence is not an FDA indication. Airway cytogens sit in a Russian experimental-gerontology literature with limited Western replication. “Oral bioavailability because PEPT1” is real peptide-transport biology; it is not proof this SKU treats the organ disease. Gray-market identity is a live problem - HPLC is the only way to know the vial is the sequence on the label. Confirm the label is Chonluten not Honluten.

Full 41-map: Khavinson bioregulators index · Bioregulator stacks

Research Use Cases

  • ✓EDG identity vs Bronchogen vs Honluten
  • ✓Not surfactant or alveolar-function treatment

Dosing

PhaseDoseFrequencyNotes
Khavinson Protocol1–2 capsules/day or 1–2 mg SCDaily for 10–30 day courses, 1-2x per yearLung/respiratory bioregulator. Often used strategically with Bronchogen.

Administration

Route / form
Two real SKUs: Cytomed oral capsules (swallowed) or a lyophilized research vial reconstituted for subcutaneous injection. Nobody manufactures these as sublingual tablets.
Timing
Capsules: morning, about 30 minutes before meals. Research vial (SubQ): food does not change the injection.
Empty stomach?
Capsules: yes - Swallow on an empty stomach, about 30 minutes before meals. Reconstituted vial (SubQ): food does not change the injection. Cytomed boxes sometimes print “with food” because they are labeled as supplements; the manufacturer user-guide preference is before meals.

Chonluten: oral vs SubQ

Cytomed oral capsule
Bioavailability
No published human F% for this SKU. Di- and tripeptides can ride PEPT1/LAT; that is transporter biology, not proof the capsule treats the named organ. Cytomed cytogen capsules are swallowed.
Dose note
Chonluten Cytomed cytogen capsules: 1–2 capsules/day, typically 10–30 day courses. No reconstitution. Swallow; do not melt under the tongue. Swallowed with water. Morning, about 30 minutes before meals, is manufacturer user-guide folklore. Cytomed boxes sometimes print “with food” because they are labeled as supplements. That is not a published absorption RCT for this SKU. Pair: Taxorest is the bronchial Cytomax. Bronchogen (AEDL) is the other airway cytogen. Honluten is a lung-extract catalog SKU, not this tripeptide.
Advantages
  • Official Cytomed cytogen SKU is a swallowed capsule. No BAC water, no syringe.
  • Matches how Cytomed ships the poster line.
  • Nobody manufactures this as a sublingual tablet.
Considerations
  • Capsule milligrams are not 1–2 mg SC. Do not convert a research-vial protocol into capsule counts by arithmetic theater.
  • Empty-stomach timing is user-guide folklore plus PEPT1 logic, not a cited human PK study for this SKU.
  • Chonluten is EDG, lungs and bronchi. The Honluten one-letter collision is how people buy the extract bottle. Two airway cytogens (EDG vs AEDL) is manufacturer reality, not a duplicate SKU.
  • Confirm the label is Chonluten, not Honluten, before you swallow a 10–30 day course.
Research vial SubQ
Bioavailability
No published human PK curve for this cytogen. Research-chem SubQ is the gray-market route. Class estimate is minutes-to-hours, not a depot ester.
Dose note
Research lyophilized vial: reconstitute with bacteriostatic water, sterile technique, SubQ. Class pattern is about 1–2 mg daily for on the order of 10 days, not a 12-week GLP-1 titration. Food does not change the injection. Do not convert Cytomed capsule counts into vial milligrams. Pair: Taxorest is the bronchial Cytomax. Bronchogen (AEDL) is the other airway cytogen. Honluten is a lung-extract catalog SKU, not this tripeptide.
Advantages
  • Vial math is checkable if the COA matches the sequence on the label.
  • Food timing is irrelevant for SubQ.
  • Short pulsed courses match how the school used defined synthetics.
Considerations
  • Gray-market identity: HPLC is the only way to know the cake is EDG (Glu-Asp-Gly).
  • Not a Western Phase 3. Russian experimental-gerontology literature is real and concentrated.
  • Not a sublingual tablet and not a Cytomax complex.
  • Chonluten is EDG, lungs and bronchi. The Honluten one-letter collision is how people buy the extract bottle. Two airway cytogens (EDG vs AEDL) is manufacturer reality, not a duplicate SKU.
  • Not a LABA, not nintedanib. Post-viral fibrosis YouTube protocols are not pulmonary rehab.
Recommendation: Two SKUs. Swallow Cytomed Chonluten capsules (no recon, not sublingual) or BAC-reconstitute a research vial for SubQ at the 1–2 mg / ~10-day class pattern. Food does not change the shot. Pair: Taxorest is the bronchial Cytomax. Bronchogen (AEDL) is the other airway cytogen. Honluten is a lung-extract catalog SKU, not this tripeptide. Chonluten is EDG, lungs and bronchi. The Honluten one-letter collision is how people buy the extract bottle. Two airway cytogens (EDG vs AEDL) is manufacturer reality, not a duplicate SKU. Russian literature is real; Western Phase 3 is not. Keep prescribed airway drugs. COPD is not a cytogen label.

Timeline

Day 1-10 (course)
Lung epithelial gene expression restoration initiated.
Month 3-6
Improved lung capacity and oxygen utilization.

Who it is for

Respiratory Health

Low

Lung bioregulator. Restores age-suppressed pulmonary gene expression.

Reconstitution

VialWaterConcentrationExample dose
Lyophilized cytogen (if the SKU is a vial)Follow the COA fillDo the mathCapsules skip this step. Cytomax complexes are not this molecule.

Change vial size or water volume? Open the reconstitution calculator.

Safety & Considerations

Research peptide. Extensively used in Russian clinical protocols. Russian clinic history is not a US safety NDA.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

  • A defined sequence is not an FDA indication.
  • Gray-market identity is a live problem. HPLC beats a blog table.
  • Do not paste a sibling cytogen’s papers onto this SKU.
  • This site will not treat the named organ disease from a peptide page.

Verdict

Chonluten is the synthetic EDG cytogen for Lungs and bronchi. Khavinson’s group published in this family. That is a concentrated literature, not a Western Phase 3. Capsules and vials are different SKUs.

Interactions & Contraindications

This site will not treat lung disease from a peptide page.

Synergies & Common Stacks

+ Bronchogen →

Two respiratory cytogens. Complementary marketing is not a combo RCT.

Frequently Asked Questions

Chonluten vs Honluten vs Bronchogen vs Taxorest?▼
Chonluten = EDG cytogen. Honluten = lung-extract catalog SKU. Bronchogen = AEDL cytogen. Taxorest = bronchial Cytomax on the 21.
COPD treatment?▼
Not a labeled inhaler. Keep prescribed airway drugs.
Sequence?▼
Glu-Asp-Gly (EDG).
Oral capsule or injection?▼
Two SKUs. Cytomed Chonluten is a swallowed cytogen capsule (1–2/day, typical 10–30 day courses, morning empty-stomach folklore, no reconstitution, not a sublingual tablet). Research vials are BAC-reconstituted SubQ at about 1–2 mg for on the order of 10 days; food does not change the shot. Confirm the label is Chonluten, not Honluten. Bronchogen is AEDL.
How does Chonluten compare to Bronchogen?▼
Both target the respiratory system. Bronchogen (AEDL) targets the bronchial tubes and mucus clearance. Chonluten (EDG) targets the deeper lung tissue (alveoli) and respiratory capacity. They are often used together.

References

  1. Khavinson VKh et al. “Tissue-specific effects of peptides.” Bulletin of Experimental Biology and Medicine (2001). PMID: 11713572
  2. Khavinson VKh, Lin’kova NS, Tarnovskaya SI “Short peptides regulate gene expression.” Bulletin of Experimental Biology and Medicine (2016). PMID: 27909961
  3. Khavinson VKh, Morozov VG “Peptides of pineal gland and thymus prolong human life.” Neuroendocrinology Letters (2003). PMID: 14523363

📚 Related Articles

Epitalon: The Science of Telomerase Activation, Khavinson's Legacy, and Longevity Peptides
14 min read • Longevity
Where to get itOral bioregulator

Affiliate links: we earn a commission if you buy, at no extra cost to you.

Lungard is Vita-Stream's US-made lung bioregulator (Vita Peptides' own house line), a different product from Chonluten. No trial has tested it.

Browse Lungard

Get Chonluten from Vita-Stream, which sells the GARMONIA Cytomax and Cytogen oral capsules. No reconstitution math on a capsule bottle.

Browse Chonluten

Use code KymataLabs at checkout

See all sources and our full review

← Back to Peptide Library·Bioregulator stacks